Interactions between chronic renal disease and periodontal disease

Oral Diseases

Volumn 14, Issue 1, 2008, Pages 1-7

  Craig, R G ^a  

^a NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

Author keywords

End stage renal disease; Hemodialysis; Periodontal diseases; Periodontitis; Peritoneal dialysis; Renal transplantation

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CYCLOSPORIN A; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; TACROLIMUS; VASCULAR CELL ADHESION MOLECULE 1;

CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; GINGIVA HYPERPLASIA; GLOMERULONEPHRITIS; HEART INFARCTION; HEMODIALYSIS; HUMAN; HYPERPARATHYROIDISM; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIODONTAL DISEASE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; STROKE;

ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CAUSE OF DEATH; HUMANS; IMMUNOSUPPRESSION; PERIODONTAL DISEASES; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; SURVIVAL RATE;

EID: 37349031405     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2007.01430.x     Document Type: Review

References (61)

1. Al-Wahadni A Al-Omari MA (2003). Dental diseases in a Jordanian population on renal dialysis. Quintessence Int 34: 343 347.
2. Bots CP, Poortermann JHG, Brand HS et al (2006). The oral health status of dentate patients with chronic renal failure undergoing dialysis therapy. Oral Dis 12: 176 180.
3. Brown LJ, Brunelle JA, Kingman A (1996). Periodontal status in the United State, 1988-91: prevalence, extent, and demographic variation. J Dent Res 75: 672 683.
4. Buhlin K, Gustafsson A, Pockly AG (2003). Risk factors for cardiovascular disease in patients with periodontitis. Eur Heart J 24: 2099 2107.
5. Castillo A, Mesa F, Liebana J et al (2007). Periodontal and oral microbiological status of an adult population undergoing haemodialysis: a cross-sectional study. Oral Diseases 13: 198 205.
6. Cesari M, Penninz B, Newman AB et al (2003). Inflammatory markers and onset of cardiovascular events. Results from the ABC study. Circulation 108: 2317 2322.
7. Chang M-K, Binder CJ, Torzewski M, Witztum JL (2002). C-reactive protein binds to both oxidized LDL and apopotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci U S A 99: 13043 13048.
8. Chen L-P, Chiang C-K, Chan C-P, Hung K-Y, Huang C-S (2006). Does periodontitis reflect inflammation and malnutrition status in hemodialysis patients? Am J Kidney Dis 47: 815 822.
9. Chuang S-F, Sung J-M, Kuo S-C, Huang J-J, Lee S-Y (2005). Oral and dental manifestations in diabetic and nondiabetic uremic patients receiving hemodialysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99: 689 695.
10. Cohen G, Haag-Weber M, Horl WH (1997). Immune dysfunction in uremia. Kidney Int 62: s79 s82.
11. Craig RG, Yip JK, So MK, Boylan RJ, Socransky SS, Haffajee AD (2003). Relationship of destructive periodontal disease to the acute-phase response. J Periodontol 74: 1007 1016.
12. D'Aiuto F, Parkar M, Andreou G et al (2004). Periodontitis and systemic inflammation: Control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 83: 156 160.
13. D'Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS (2005). Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 84: 269 273.
14. Davidovich E, Davidovits M, Eielman E, Schwartz Z, Bimstein E (2005). Pathophysiology, therapy, and oral implications of renal failure in children and adolescents: an update. Pediatr Dent 27: 98 106.
15. Duran I, Erdemir EO (2004). Periodontal treatment needs of patients with renal disease receiving haemodialysis. Int Dent J 54: 274 278.
16. Ellis JS, Seymour RA, Taylor JJ, Thomason JM (2004). Prevalence of gingival overgrowth in transplant patients immunosuppressed with tacrolimus. J Clin Periodontol 31: 126 131.
17. Fogo A, Kon W (2004). Pathophysiology of progressive chronic renal disease. In: Avner EED, Harmon WE, Niaudet P, eds. Textbook of Pediatric Nephrology, 5th edn. Lippincot, Williams & Wilkins: Philadelphia, pp. 1267 1480.
18. Frankenthal S, Nakhoul F, Machtei EE et al (2002). The effect of secondary hyperparathyroidism and hemodialysis on alveolar bone and periodontium. J Clin Periodontol 29: 479 483.
19. Fredriksson MI, Figueredo CMS, Gustafsson A, Bergstrom KG, Asman BE (1999). Effect of periodontitis and smoking on blood leukocytes and acute-phase proteins. J Periodontol 70: 1355 1360.
20. Gavalda C, Bagan JV, Scully C, Silvestre FJ, Milian MA, Jimenez Y (1999). Renal hemodialysis patients: oral, salivary, dental and periodontal findings in 105 adult cases. Oral Dis 5: 299 302.
21. Grossi SG, Zambon JJ, Ho AW et al (1994). Assessment of risk for periodontal disease. Risk indicators for attachment loss. J Periodontol 65: 260 267.
22. Hernandez G, Arriba L, Frias MC et al (2003). Conversion from cyclosporine A to tacrolimus as a non-surgical alternative to reduce gingival enlargement: a preliminary case series. J Periodontol 74: 1816 1823.
23. Katz J (2001). Elevated blood glucose levels in patients with severe periodontitis. J Clin Periodontol 28: 710 712.
24. Kerr RA (2001). Update on renal disease for the dental practitioner. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92: 9 16.
25. Kitsou VK, Konstantinidis A, Siamopoulos C (2000). Chronic renal failure and periodontal disease. Ren Fail 22: 307 318.
26. Klassen JT, Krasko BM (2002). The dental health status of dialysis patients. J Can Dent Assoc 68: 34 38.
27. Kshirsagar AV, Moss KL, Elter JR, Beck JD, Offenbacher S, Falk RJ (2005). Periodontal disease is associated with renal insufficiency in the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis 45: 650 657.
28. Lacson E, Levin NW (2004). C-reactive protein and end-stage renal disease. Semin Dial 17: 438 448.
29. Lagrand WK, Niessen HW, Wilbink GJ et al (1997). C-reactive protein co-localizes with complement in human hearts during acute myocardial infarction. Circulation 95: 97 103.
30. Levey AS, Coresh J, Greene T et al (2006). Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247 254.
31. Libby P (2002). Inflammation in atherosclerosis. Nature 420: 868 874.
32. Little JW, Falace DA, Miller CS, Rhodus NL (2002). Chronic renal failure and dialysis. In: Little JW, Falace DA, Miller CS, Rhodus NL, eds. Dental Management of the Medically Compromised Patient. Mosby, Inc: St Louis, MO, pp. 147 160.
33. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen P, van der Velden U (2000). Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 71: 1528 1534.
34. Marakoglu IK, Gursoy KD, Demirer S, Sezer H (2003). Periodontal status of chronic renal failure patients receiving hemodialysis. Yonsei Med J 44: 648 652.
35. Naugle K, Darby ML, Bauman DB, Lineberger LT, Powers R (1998). The oral health status of individuals on renal dialysis. Ann Periodontol 3: 197 205.
36. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E (2001). Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 72: 1221 1227.
37. Nunn JH, Sharp J, Lambert HJ, Plant ND, Coulhtard MG (2000). Oral health in children with renal disease. Pediatr Nephrol 14: 997 1001.
38. Pai JK, Pischoon T, Ma J et al (2004). Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351: 2599 2610.
39. Paparello J, Kshirsagar A, Batlle D (2002). Comorbidity and cardiovascular risk factors in patients with chronic kidney disease. Semin Nephrol 22: 494 506.
40. Pasceri V, Willerson JT, Yeh ETH (2000). Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102: 2165 2168.
41. Pasceri V, Chang J, Willerson JT, Yeh ETH (2001). Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103: 2531 2534.
42. Pearson TA, Mensah GA, Alexander RW et al (2003). Markers of inflammation and cardiovascular disease. Application to clinical and public health practice. A statement for health care professionals from the Centers for Disease Control and the American Heart Association. Circulation 107: 499 511.
43. Proctor R, Kumar N, Stein A, Moles D, Porter S (2005). Oral and dental aspects of chronic renal failure. J Dent Res 84: 199 208.
44. Radwan-Oczko M, Boratynska M, Zietek M, Zoledziewsha M, Jondisz A (2006). The relationship of transforming growth factor β1 gene polymorphism, its plasma level and gingival overgrowth in renal transplant recipients receiving different immunosuppressive regimens. J Periodontol 77: 865 873.
45. Rahmati MA, Craig RG, Homel P, Kaysen GA, Levin NW (2002). Serum markers of periodontal disease status and inflammation in hemodialysis patients. Am J Kidney Dis 40: 983 989.
46. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997). Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973 976.
47. Ridker PM, Hennekens CH, Buring JE, Rafai N (2000). C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342: 836 843.
48. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002). Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiac events. N Engl J Med 347: 1557 1565.
49. Ridker PM, Cannon CP, Morrow D et al (2005). C-reactive protein level and outcomes after statin therapy. N Engl J Med 352: 20 28.
50. Riegden S (2003). The management of chronic and end-stage renal failure. In: Webb N, Postlewaite R, eds. Textbook of Clinical Pediatric Nephrology, 3rd edn. Oxford Medical Publications: Oxford, pp. 427 445.
51. Ross R (1999). Atherosclerosis - an inflammatory disease. N Engl J Med 340: 115 126.
52. Seikaly M, Ho PL, Emmet L, Tejani A (2001). The 12th annual report of the North American pediatric renal transplant cooperative study: renal transplantation from 1987 through 1998. Pediatr Transplant 5: 215 231.
53. Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS (2000). Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res 79: 49 57.
54. Slade GD, Ghezzi EM, Heiss G, Beck JD, Riche E, Offenbacher S (2003). Relationship between periodontal disease and C-reactive protein among adults in the atherosclerosis risk in communities study. Arch Intern Med 163: 1172 1179.
55. Somacarrera ML, Hernandez G, Acero J, Moskow BS (1994). Factors related to the incidence and severity of cyclosporine-induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 65: 671 675.
56. Souza CRD, Liberio SA, Guerra RNM (2005). Assessment of periodontal condition of kidney patients in hemodialysis. Rev Assoc Med Bras 51: 285 289.
57. Spolidorio LC, Spoldidorio DMP, Massucato EMS, Neppelenbrock KH, Camanha NH, Sanches MH (2006). Oral health in renal transplant recipients administered cyclosporine A or tacrolimus. Oral Dis 12: 309 314.
58. US Renal Data System (2005). USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD.
59. Vanholder R, De Smet R, Glorieux G et al (2003). Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int 63: 1934 1943.
60. Yeun JY, Levine RA, Mantadilok V, Kaysen GA (2000). C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis populations. Am J Kidney Dis 35: 469 476.
61. Yoshino M, Craig RG, Kuhlman MK et al (2005). Prevalence of periodontitis in hemodialysis (HD) patients at 2 sites. J Am Soc Nephrol 16: F PO781.